Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

The Intellectual Property StrategistKickerSectionsNewsLJN Newsletters

Interpreting Patent Claims: Patent Drafters Say What They Mean, But Do They Mean What They Say?

By Matthew W. Siegal and Alfi S. Guindi
August 09, 2004

What exactly does it mean to interpret claims “in light” of the specification? Do the descriptions and examples in a patent specification affect the interpretation of the patent's claims where there is no express statement that a specialized definition is being given to claim terms? Absent a specific glossary section, is it even necessary to read the specification or should the public be free to read and interpret the claims in a vacuum? Within 4 days, two separate panels of the Federal Circuit delivered seemingly conflicting answers to these questions, highlighting a growing rift regarding the significance of the specification and prosecution history to claim interpretation.

Seemingly relegating the patent specification to second-class status, the panel in Housey Pharm., Inc. v. Astrazeneca UK Ltd., 364 F.3d 1348 (Fed. Cir. 2004), began its analysis by stating that there is a “heavy presumption” that the language in a claim “carries its ordinary and customary meaning.” Based on the court's approach, this ordinary definition can be determined by looking in dictionaries. This panel stated that in order to overcome this “heavy presumption” that the dictionary definition is the controlling interpretation, the intrinsic evidence would have to “clearly disavow” the ordinary meaning. As the dissent put it, the majority categorized intrinsic evidence as an “also-ran” in claim construction.

This premium content is locked for Entertainment Law & Finance subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

CLE Shouldn't Be the Only Mandatory Training for Attorneys Image

Each stage of an attorney's career offers opportunities for a curriculum that addresses both the individual's and the firm's need to drive success.

Discovery of Claim Construction and Infringement Analysis May be Compelled Prior to a Markman Hearing Image

A defendant in a patent infringement suit may, during discovery and prior to a <i>Markman</i> hearing, compel the plaintiff to produce claim charts, claim constructions, and element-by-element infringement analyses.